CYCC Bio Green Med Solution Inc.


$ 1.84 $ 0.12 (6.98 %)    

Wednesday, 29-Oct-2025 13:21:49 EDT
QQQ $ 634.73 $ -0.89 (-0.14 %)
DIA $ 478.64 $ 0.04 (0.01 %)
SPY $ 687.89 $ -0.86 (-0.12 %)
TLT $ 91.60 $ -0.28 (-0.3 %)
GLD $ 366.90 $ -2.75 (-0.74 %)
$ 1.81
$ 1.72
$ 1.82 x 200
$ 1.86 x 500
$ 1.72 - $ 1.87
$ 1.73 - $ 101.30
8,509,970
na
na
$ 1.31
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cyclacel-pharmaceuticals-exchanges-series-c-warrants-for-559395-common-shares-in-agreement-with-accredited-investors

On September 4, 2025, Cyclacel Pharmaceuticals, Inc. (the "Company") entered into a Warrant Exchange Agreement (the ...

 cyclacel-pharmaceuticals-stock-up-346-in-massive-after-hours-rally

After sharing encouraging preclinical results for a potential biliary tract cancer treatment, Cyclacel Pharmaceuticals jumped 3...

 reported-earlier-cyclacel-announces-new-findings-supporting-use-of-plogosertib-in-biliary-tract-cancer-patients-with-high-bubr1-expression

  Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis 

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION